Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    Levomilnacipran Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Breckenridge Launches Milnacipran Hcl Tablets, Generic Version
    Breckenridge Launches Milnacipran Hcl Tablets, Generic Version

    20 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/breckenridge-announces-launch-of-milnacipran-hcl-tablets-generic-equivalent-of-savella-302718947.html

    PR NEWSWIRE
    20 Mar 2026
    Share Share
    Strides’s Generics Milnacipran Receives Tentative Approval in US
    Strides’s Generics Milnacipran Receives Tentative Approval in US

    09 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207399

    FDA
    09 Mar 2026
    Share Share
    Aurobindo's Generic Levomilnacipran Hydrochloride Receives Approval in the U.S.
    Aurobindo's Generic Levomilnacipran Hydrochloride Receives Approval in the U.S.

    06 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210826

    FDA
    06 Jan 2023
    Share Share
    Amneal Pharm's Generic Levomilnacipran Hydrochloride Receives Approval in US
    Amneal Pharm's Generic Levomilnacipran Hydrochloride Receives Approval in US

    04 Feb 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210790

    FDA
    04 Feb 2019
    Share Share
    US says Allergan's Units to Pay $38 Million to Settle Kickback Allegations
    US says Allergan's Units to Pay $38 Million to Settle Kickback Allegations

    16 Dec 2016

    // Susan Heavey REUTERS

    http://www.reuters.com/article/us-allergan-usa-forestlabs-idUSKBN1442BK

    Susan Heavey REUTERS
    16 Dec 2016
    Share Share
    Glenmark Pharmaceuticals settles patent litigation over anti-depressant drug
    Glenmark Pharmaceuticals settles patent litigation over anti-depressant drug

    21 Dec 2015

    // ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharmaceuticals-settles-patent-litigation-over-anti-depressant-drug/articleshow/50265123.cms

    ECONOMIC TIMES
    21 Dec 2015
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.